Value of total cholesterol readings earlier versus later in life to predict cardiovascular risk

[1]  ESC / EAS Guidelines for the Treatment of Dyslipidemias: Lipid Modification to Reduce Cardiovascular Risk , 2020, Digital Doctor.

[2]  A. Leiherer,et al.  Type 2 diabetes mellitus is a strong predictor of LDL cholesterol target achievement in patients with peripheral artery disease. , 2020, Journal of diabetes and its complications.

[3]  R. Vasan,et al.  Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All‐Cause Mortality: Observations From the Framingham Study Over 35 Years , 2019, Journal of the American Heart Association.

[4]  A. Dominiczak,et al.  Medical Misinformation: Vet the Message! , 2019, Circulation.

[5]  V. Fuster,et al.  Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors. , 2017, Journal of the American College of Cardiology.

[6]  J. Gallacher,et al.  Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis , 2017, American journal of epidemiology.

[7]  Lale Tokgözoğlu,et al.  Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel , 2017, European heart journal.

[8]  Hima Bindu Gujjarlamudi,et al.  Polytherapy and drug interactions in elderly , 2016, Journal of mid-life health.

[9]  C. Schmidt,et al.  Utility of repeat serum cholesterol measurements for assessment of cardiovascular risk in primary prevention , 2016, European journal of preventive cardiology.

[10]  O. Franco,et al.  Mendelian Randomization Causal Analysis LDL cholesterol still a problem in old age? A Mendelian randomization study , 2015 .

[11]  P. Libby,et al.  Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy. , 2013, European heart journal.

[12]  Lu Tian,et al.  A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data , 2013, Statistics in medicine.

[13]  L. Risch,et al.  Relation of albuminuria to angiographically determined coronary arterial narrowing in patients with and without type 2 diabetes mellitus and stable or suspected coronary artery disease. , 2011, The American journal of cardiology.

[14]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[15]  Ewout W Steyerberg,et al.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.

[16]  K. Christensen,et al.  Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. , 2010, Age and ageing.

[17]  T. Lehtimäki,et al.  Follow‐ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: Levels and 6‐year changes in risk factors , 2010, Journal of internal medicine.

[18]  F. Harrell,et al.  Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association , 2009, Circulation.

[19]  J. Jansson,et al.  Time trends in population cholesterol levels 1986–2004: influence of lipid‐lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study , 2006, Journal of internal medicine.

[20]  Guoqing Diao,et al.  Estimation of time‐dependent area under the ROC curve for long‐term risk prediction , 2006, Statistics in medicine.

[21]  P. Sorlie,et al.  Trends in Serum Lipids and Lipoproteins of Adults 1960-2002 , 2006 .

[22]  J. Klenk,et al.  Obesity and incidence of cancer: a large cohort study of over 145 000 adults in Austria , 2005, British Journal of Cancer.

[23]  P. Sorlie,et al.  Trends in serum lipids and lipoproteins of adults, 1960-2002. , 2005, JAMA.

[24]  M. Ezekowitz,et al.  High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. , 2005, European heart journal.

[25]  D. Levy,et al.  Lifetime risk of coronary heart disease by cholesterol levels at selected ages. , 2003, Archives of internal medicine.

[26]  A. Weverling-Rijnsburger,et al.  High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. , 2003, Archives of internal medicine.

[27]  H. Concin,et al.  Long-term tracking of cardiovascular risk factors among men and women in a large population-based health system: the Vorarlberg Health Monitoring & Promotion Programme. , 2003, European heart journal.

[28]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[29]  J. Witztum,et al.  Shifting the diagnosis and treatment of atherosclerosis to children and young adults: a new paradigm for the 21st century. , 2002, Journal of the American College of Cardiology.

[30]  T. Lumley,et al.  Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.

[31]  A. Weverling-Rijnsburger,et al.  Total cholesterol and risk of mortality in the oldest old , 1997, The Lancet.

[32]  W. Insull.  The problem of compliance to cholesterol altering therapy , 1997, Journal of internal medicine.

[33]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[34]  K. Anderson,et al.  Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. , 1994, Journal of gerontology.

[35]  F. Follath,et al.  Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. , 1994, Circulation.

[36]  N J Wald,et al.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? , 1994, BMJ.

[37]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[38]  Zhao Shui-ping,et al.  Criteria for Evaluation of Novel Markers of Cardiovascular Risk , 2011 .

[39]  Adrian Hernandez,et al.  Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. , 2009, American heart journal.

[40]  Doris Ma Fat,et al.  WHO Library Cataloguing-in-Publication Data , 2001 .

[41]  D. Levy,et al.  Lipids and risk of coronary heart disease. The Framingham Study. , 1992, Annals of epidemiology.

[42]  R. Little.  A Test of Missing Completely at Random for Multivariate Data with Missing Values , 1988 .